187 related articles for article (PubMed ID: 17188434)
1. Calretinin: an immunohistochemical marker for the normal functional endometrial stroma and alterations of the immunoreactivity in dysfunctional uterine bleeding.
Al Moghrabi H; Elkeilani A; Thomas JM; Mai KT
Pathol Res Pract; 2007; 203(2):79-83. PubMed ID: 17188434
[TBL] [Abstract][Full Text] [Related]
2. Calretinin and CD34 immunoreactivity of the endometrial stroma in normal endometrium and change of the immunoreactivity in dysfunctional uterine bleeding with evidence of 'disordered endometrial stroma'.
Mai KT; Teo I; Al Moghrabi H; Marginean EC; Veinot JP
Pathology; 2008 Aug; 40(5):493-9. PubMed ID: 18604736
[TBL] [Abstract][Full Text] [Related]
3. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma.
Hamid AA; Mandai M; Konishi I; Nanbu K; Tsuruta Y; Kusakari T; Kariya M; Kita M; Fujii S
Cancer; 2002 Feb; 94(4):997-1005. PubMed ID: 11920468
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma.
Götte M; Wolf M; Staebler A; Buchweitz O; Kelsch R; Schüring AN; Kiesel L
J Pathol; 2008 Jul; 215(3):317-29. PubMed ID: 18473332
[TBL] [Abstract][Full Text] [Related]
5. Expression of angiotensin II and its receptor subtypes in endometrial hyperplasia: a possible role in dysfunctional menstruation.
Li XF; Ahmed A
Lab Invest; 1996 Aug; 75(2):137-45. PubMed ID: 8765314
[TBL] [Abstract][Full Text] [Related]
6. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H
Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221
[TBL] [Abstract][Full Text] [Related]
7. Total sialic acid content in endometrial cancer tissue in relation to normal and hyperplastic human endometrium.
Paszkowska A; Cybulski M; Semczuk A; Postawski K; Berbe H
Cancer Detect Prev; 2000; 24(5):459-63. PubMed ID: 11129988
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and secretion of proteins by the human proliferative, secretory, decidual and hyperplastic endometrium.
Shivaji S; Ahmad MB; Rao KM
Cell Mol Biol (Noisy-le-grand); 1995 Jun; 41(4):555-63. PubMed ID: 7549792
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization of macrophage CD68+, HLA-DR+, L1+ and CD44+ subsets in uterine endometrium during different phases of menstrual cycle.
Kar M; Sengupta J; Kumar S; Bhargava VL; Ghosh D
Indian J Physiol Pharmacol; 2004 Jul; 48(3):293-303. PubMed ID: 15648401
[TBL] [Abstract][Full Text] [Related]
10. Inhibin (10.7 kD prostatic peptide) in normal, hyperplastic, and malignant human endometria: an immunohistochemical study.
Teni TR; Sampat MB; Sheth NA
J Pathol; 1992 Sep; 168(1):35-40. PubMed ID: 1453268
[TBL] [Abstract][Full Text] [Related]
11. Endometrial eosinophilic syncytial change related to breakdown: immunohistochemical evidence suggests a regressive process.
Shah SS; Mazur MT
Int J Gynecol Pathol; 2008 Oct; 27(4):534-8. PubMed ID: 18753967
[TBL] [Abstract][Full Text] [Related]
12. Laminin production by human endometrial stromal cells relates to the cyclic and pathologic state of the endometrium.
Faber M; Wewer UM; Berthelsen JG; Liotta LA; Albrechtsen R
Am J Pathol; 1986 Sep; 124(3):384-91. PubMed ID: 2945438
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis in endometria of dysfuntional uterine bleeding women.
Rekha K; Malini A; Xavier R; Baba K
Med J Malaysia; 2005 Mar; 60(1):41-5. PubMed ID: 16250278
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis in normal, hyperplastic, and neoplastic endometrium.
Morgan KG; Wilkinson N; Buckley CH
J Pathol; 1996 Jul; 179(3):317-20. PubMed ID: 8774489
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone-related peptide (PTH-rp) in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis.
Mylonas I; Makovitzky J; Shabani N; Richter DU; Jeschke U; Briese V; Friese K
Anticancer Res; 2005; 25(3A):1633-8. PubMed ID: 16033073
[TBL] [Abstract][Full Text] [Related]
16. Endometrial glandular and stromal breakdown, part 2: cytomorphology of papillary metaplastic changes.
Norimatsu Y; Shimizu K; Kobayashi TK; Moriya T; Kaku T; Tsukayama C; Miyake Y; Ohno E
Diagn Cytopathol; 2006 Oct; 34(10):665-9. PubMed ID: 16955472
[TBL] [Abstract][Full Text] [Related]
17. Ki-67, Bcl-2 and p53 expression in endometrial polyps and in the normal endometrium during the menstrual cycle.
Maia H; Maltez A; Studart E; Athayde C; Coutinho EM
BJOG; 2004 Nov; 111(11):1242-7. PubMed ID: 15521869
[TBL] [Abstract][Full Text] [Related]
18. Histopathogenesis of endometrium with asynchronous glands in dysfunctional uterine bleeding.
Mai KT; Teo I; Veinot JP; Senterman M; Nguyen B
Histopathology; 2009 Jul; 55(1):126-30. PubMed ID: 19614778
[No Abstract] [Full Text] [Related]
19. Immunohistochemical pattern of protein P21, cyclin D1 and cyclin E in endometrial hyperplasia.
Brucka A; Bartczak P; Ratyńska M; Sporny S
Pol J Pathol; 2009; 60(1):19-25. PubMed ID: 19670700
[TBL] [Abstract][Full Text] [Related]
20. Immunological localization of syndecan-1 in human endometrium throughout the menstrual cycle.
Lai TH; King JA; Shih IeM; Vlahos NF; Zhao Y
Fertil Steril; 2007 Jan; 87(1):121-6. PubMed ID: 17113089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
